TRVI - CIK 0001563880
The table below shows Trevi Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.41M | $56.87M | $117.06M | $19.37M | $16.05M | $12.96M |
| Short-term investments | $152.37M | $138.06M | $86.83M | $83.88M | $49.44M | $56.53M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $176.12M |
| $198.30M |
| $207.23M |
| $105.62M |
| $67.34M |
| $72.13M |
| Property, plant & equipment | $265.00K | $213.00K | $239.00K | $277.00K | $174.00K | $198.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $179.61M | $199.36M | $208.34M | $107.00M | $68.91M | $73.81M |
| Accounts payable | $2.21M | $2.71M | $2.97M | $1.42M | $1.61M | $1.51M |
| Total current liabilities | $7.12M | $9.04M | $9.24M | $6.87M | $9.12M | $6.75M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $7.48M | $9.57M | $9.85M | $7.55M | $9.94M | $7.64M |
| Retained earnings | -$343.00M | -$321.49M | -$309.69M | -$297.38M | -$275.63M | -$262.39M |
| Total equity | $172.13M | $189.79M | $198.49M | $99.46M | $58.97M | $66.17M |